Yearly Archives: 2026

Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up

VOICE OF ASIA - January 5, 2026 0

HAIKOU, China, Jan. 5, 2026 /PRNewswire/ -- A news report from Haikou Municipal Bureau of Tourism, Culture, Radio, Television and Sports: As a key hub of...

Agoda Reveals Growing Interest for Year-End Domestic Travel with Kuala Lumpur at the Forefront in 2025

VOICE OF ASIA - January 5, 2026 0

All top five domestic destinations experienced positive growth in accommodation searches compared to previous yearSINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Malaysian travelers are increasingly...

Indonesia’s Open-Sector Strategy Is Quietly Redefining Foreign Ownership Rules

VOICE OF ASIA - January 5, 2026 0

Indonesia’s investment policy has undergone a structural shift that is still widely misunderstood outside the country. While headlines often focus on licensing hurdles or...

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

VOICE OF ASIA - January 5, 2026 0

HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S....

Prospek Harga Emas Masih Konstruktif di Tengah Dinamika Global

VOICE OF ASIA - January 5, 2026 0

Harga Emas (XAU/USD) global kembali menunjukkan kecenderungan menguat pada perdagangan hari ini, seiring meningkatnya ketegangan geopolitik dan membaiknya sentimen teknikal di pasar. Emas saat ini...

Pos Kesehatan Stasiun Penumpang, KAI Divre III Pastikan Layanan Kesehatan Pelanggan dan Petugas Tetap Optimal

VOICE OF ASIA - January 5, 2026 0

Palembang, 5 Januari 2026 - Dalam rangka memastikan keselamatan dan kenyamanan perjalanan pelanggan, PT Kereta Api Indonesia (Persero) Divisi Regional III Palembang memperkuat layanan...

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

VOICE OF ASIA - January 5, 2026 0

-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30...